Publications     News     About    Contact

Solutions & Services

Therapeutic expertise

Why APICES

Submit RFI/RFP
MENU

Cardiometabolic expertise

Cardiometabolic trials are defined by scale and duration. Patient populations are large, but studies often run long, involve multiple comorbidities, and rely on sustained engagement over extended follow-up periods. The primary challenge is not initial enrollment, but maintaining consistency in execution, data capture, and patient adherence over time.

APICES brings cardiometabolic expertise grounded in studies where endurance matters more than speed. We understand how protocol complexity, visit burden, and competing standard-of-care treatments affect retention and data completeness. This experience informs study designs that balance scientific ambition with what sites and patients can realistically sustain.

Clinical trials in Cardiometabolic Diseases

Cardiometabolic patients recruited

Why APICES in Cardiometabolic Disease

In cardiometabolic development, execution risk accumulates gradually. Small deviations in site performance, follow-up discipline, or data collection compound over time and can undermine outcomes. APICES focuses on early alignment between design, feasibility, and operations to prevent that drift. The result is a study setup that supports long-term participation, consistent site performance, and data that remain robust through to final analysis.
  • Clinical trial expertise across cardiometabolic indications
  • Experience in diabetes, dyslipidemia, hypertension, cardiovascular outcomes studies and beyond
  • Realistic, data-driven feasibility and patient recruitment strategies
  • Strong European investigator and site networks in cardiometabolic research
  • Predictable execution of complex, long-term cardiometabolic trials

Talk to our team about how execution realities may shape the feasibility and timelines of your hematology study.

Early Clinical development

When moving from protocol to first European execution →

Late Clinical development

When scale, consistency, and delivery discipline matter →